| RS1163162816 |
WNT10B
|
Health Risk |
Pathogenic/Likely pathogenic |
Split hand-foot malformation 6, Split hand-foot malformation 6 |
| RS116316900 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal Kniest-like syndrome, Schwartz-Jampel syndrome |
| RS1163170578 |
COQ4
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome, Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome |
| RS116317145 |
AMHR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1163172447 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS116317506 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Familial thoracic aortic aneurysm and aortic dissection |
| RS1163185721 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, Central core myopathy |
| RS116319889 |
SPG7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia |
| RS116320983 |
HADHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS116321057 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, NOTCH2-related disorder |
| RS1163218519 |
PNKP
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS1163221525 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Lymphangiomyomatosis |
| RS116322271 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS1163223024 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1163242822 |
TTLL5
|
Health Risk |
Pathogenic |
— |
| RS1163244913 |
DSP
|
Health Risk |
Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic right ventricular dysplasia 8 |
| RS1163252803 |
SIK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 30 |
| RS1163253431 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1163253626 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1163264200 |
GALNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1163269726 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Cockayne syndrome type 2 |
| RS116327839 |
DIS3L2
|
Health Risk |
Conflicting classifications of pathogenicity |
Perlman syndrome, Perlman syndrome |
| RS1163280866 |
ALOXE3
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 3, Autosomal recessive congenital ichthyosis 3 |
| RS116329113 |
DNAAF11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 19, Primary ciliary dyskinesia 19 |
| RS1163303148 |
ASPM
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly, Lissencephaly |
| RS1163308590 |
ADGRV1
|
Health Risk |
Pathogenic/Likely pathogenic |
ADGRV1-related disorder, Usher syndrome |
| RS1163308868 |
MYPN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1KK, Cardiovascular phenotype |
| RS116330917 |
CENPE
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, See cases |
| RS116331296 |
COG7
|
Health Risk |
Conflicting classifications of pathogenicity |
COG7 congenital disorder of glycosylation, COG7-related disorder |
| RS1163340926 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS1163344946 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Familial isolated arrhythmogenic right ventricular dysplasia |
| RS1163346468 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS1163346501 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS1163351205 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1163356968 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, GLDC-related disorder |
| RS1163368452 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS116338839 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 3, Renal-hepatic-pancreatic dysplasia 1 |
| RS1163399365 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS116339967 |
DNAAF4
|
Health Risk |
Conflicting classifications of pathogenicity |
DNAAF4-related disorder, Inborn genetic diseases |
| RS116340633 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS1163419871 |
BTD
|
Health Risk |
Likely pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS1163458825 |
MICAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1163462384 |
MMACHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS116347156 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia of anesthesia, Hypokalemic periodic paralysis |
| RS1163473923 |
LARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1163477792 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1163486377 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS116348786 |
C8B
|
Health Risk |
Conflicting classifications of pathogenicity |
Type II complement component 8 deficiency, Type II complement component 8 deficiency |
| RS1163488527 |
DYSF
|
Health Risk |
Pathogenic |
— |
| RS116349687 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1163497041 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1163522093 |
AMN
|
Health Risk |
Pathogenic |
Imerslund-Grasbeck syndrome type 2, Imerslund-Grasbeck syndrome type 2 |
| RS1163525582 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17 |
| RS1163532771 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1163546262 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS1163546793 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS116355217 |
LRBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS116355882 |
NPAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS116356543 |
RHAG
|
Health Risk |
Conflicting classifications of pathogenicity |
RHAG-related disorder, RHAG-related disorder |
| RS1163573848 |
SLC25A4
|
Health Risk |
Pathogenic |
— |
| RS1163577336 |
CLCN7
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive osteopetrosis 4, Autosomal recessive osteopetrosis 4 |
| RS116358011 |
CC2D2A
|
Health Risk |
Pathogenic |
Meckel syndrome, type 6 |
| RS1163583945 |
MAPK8IP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without variable brain abnormalities, NEDBA |
| RS1163596220 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS116360985 |
BMP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1163615607 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1163620394 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS116364105 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS1163650910 |
LZTR1
|
Health Risk |
Pathogenic |
LZTR1-related disorder, LZTR1-related disorder |
| RS116365681 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spherocytosis, Hereditary spherocytosis type 1 |
| RS1163672028 |
LAMA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1JJ, Cardiovascular phenotype |
| RS116367260 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa |
| RS1163673587 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Familial thoracic aortic aneurysm and aortic dissection |
| RS1163683032 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Brittle cornea syndrome 1 |
| RS1163698357 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian cancer, Werner syndrome |
| RS1163700577 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1163707779 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS1163709490 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1163710370 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS116373169 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 4 |
| RS1163732372 |
PIGB
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 80 |
| RS1163745614 |
COX15
|
Health Risk |
Pathogenic |
— |
| RS1163766811 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Inborn genetic diseases |
| RS1163772841 |
PIEZO1
|
Health Risk |
Pathogenic |
Lymphatic malformation 6, Lymphatic malformation 6 |
| RS1163785853 |
CSRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 12, Dilated cardiomyopathy 1M |
| RS116378993 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, Inborn genetic diseases |
| RS116380142 |
FANCI
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group I |
| RS1163816425 |
IVD
|
Health Risk |
Conflicting classifications of pathogenicity |
Isovaleryl-CoA dehydrogenase deficiency, Isovaleryl-CoA dehydrogenase deficiency |
| RS1163833540 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1163840810 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease, Polycystic kidney disease 2 |
| RS1163854599 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS1163861044 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1163866901 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1163874095 |
AHI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Joubert syndrome 3 |
| RS1163879822 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1163895765 |
NAGS
|
Health Risk |
Likely pathogenic |
Hyperammonemia, type III |
| RS116389839 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Chitotriosidase deficiency |
| RS116390200 |
TPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of iodide peroxidase, Deficiency of iodide peroxidase |
| RS116392938 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1163930676 |
DALRD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 86 |